Full Text View
Tabular View
No Study Results Posted
Related Studies
Moxifloxacin Plus Metronidazole Versus Piperacillin/Tazobactam for the Treatment of Patients With Intra-Abdominal Abscesses (MEMO)
This study is currently recruiting participants.
Study NCT00629135   Information provided by Hannover Medical School
First Received: February 25, 2008   Last Updated: March 4, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Abscess, Intra-Abdominal
Additional conditions recognized in this trial
Abdominal Abscess
Abscess
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Suppuration
Additional drug interventions recognized in this trial
Metronidazole
Moxifloxacin
Penicillanic Acid
Piperacillin
Piperacillin-tazobactam combination product
Tazobactam
More general drug interventions related to this trial
Anti-Bacterial Agents
Anti-Infective Agents
Antiparasitic Agents
Antiprotozoal Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
Hannover Medical School
Bayer AG Leverkusen


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services